Australia's leading independent law firm, Corrs Chambers Westgarth, has advised Medibank on its acquisition of a non-controlling 33.4% economic interest in the Myheath Medical Group, a leading operator of primary care clinics.
This strategic acquisition by Medibank recognises the vital role of GPs in the community and the positive impact they have on the healthcare system.
A cross-practice Corrs team led by partners Sandy Mak (Corporate), Mark McCowan (Competition), Rommel Harding-Farrenberg (Banking and Finance), Stephen Price (Employment), Eugenia Kolivos (Intellectual Property), Helen Clarke (Intellectual Property) and Nathaniel Popelianski (Property and Real Estate) advised Medibank on all aspects of the transaction, from structuring and due diligence to the signing of the transaction documents.
Corrs will continue to advise Medibank up to completion of the transaction, which is expected to take place in March 2021.
Commenting on the matter, Corrs lead Partner Sandy Mak said: "It has been a pleasure and privilege to work on another strategic transaction with Medibank. It was a great team effort involving a wide range of Corrs practice groups across the country."
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
|Chambers Asia Pacific Awards 2016 Winner
Client Service Award
|Employer of Choice for Gender Equality